keyword
https://read.qxmd.com/read/38634867/cytomegalovirus-infection-as-a-rare-cause-of-colitis
#1
JOURNAL ARTICLE
José María Rodríguez Lucas, Emilio Peña Ros, Francisco Miguel González Valverde
A 62 year-old-man with low anterior rectal resection and protective ileostomy, for low rectal neo and neoadjuvant QT +RT. Then ileostomy closure without incidences. On the 3rd postoperative day, he started with fever peaks and diarrhea. An abdominal CT scan showed diffuse thickening of the wall of the descending colon compatible with colitis and colonoscopy showed deep rectal ulcers with punch-like morphology with hyperemic mucosa with erythematous stippling of erosive appearance, showing this ulcerative pattern with numerous lesions and intensely edematous and congestive mucosa covered with abundant fibrinopurulent exudate in the descending colon...
April 18, 2024: Revista Española de Enfermedades Digestivas
https://read.qxmd.com/read/38626794/a-lentivirus-vectored-feline-erythropoietin-gene-therapy-strategy-in-tissue-culture-and-rodent-models-for-the-potential-treatment-of-chronic-renal-disease-associated-anemia
#2
JOURNAL ARTICLE
Sarah E Cook, Diego Castillo, Tatiana Wolf, Chadwick Hillman, Katherine Bauer, Sonyia Williams, Brian G Murphy
OBJECTIVE: The aim of this study was to assess the efficacy and safety of a third-generation lentivirus-based vector encoding the feline erythropoietin (EPO) (feEPO) gene in vitro and in rodent models in vivo. This vector incorporates a genetic mechanism to facilitate the termination of the therapeutic effect in the event of supraphysiologic polycythemia, the herpes simplex virus thymidine kinase (HSV-TK) "suicide gene." ANIMALS: CFRK cells and replication-defective lentiviral vectors encoding feEPO were used for in vitro experiments...
April 20, 2024: American Journal of Veterinary Research
https://read.qxmd.com/read/38619252/combination-of-ganciclovir-and-trifluridine-prevents-drug-resistance-emergence-in-hsv-1
#3
JOURNAL ARTICLE
Hanna Helena Schalkwijk, Neesha Rajesh Shewakramani, Kalyan Das, Graciela Andrei, Robert Snoeck
Ocular herpes simplex virus 1 (HSV-1) infections can lead to visual impairment. Long-term acyclovir (ACV) prophylaxis reduces the frequency of recurrences but is associated with drug resistance. Novel therapies are needed to treat drug-resistant HSV-1 infections. Here, we describe the effects of trifluridine (TFT) in combination with ACV or ganciclovir (GCV) on HSV-1 replication and drug-resistance emergence. Wild-type HSV-1 was grown under increasing doses of one antiviral (ACV, GCV, or TFT) or combinations thereof (ACV + TFT or GCV + TFT)...
April 15, 2024: Antimicrobial Agents and Chemotherapy
https://read.qxmd.com/read/38616855/herpes-simplex-keratitis-a-brief-clinical-overview
#4
REVIEW
Mutali Musa, Ehimare Enaholo, Gladness Aluyi-Osa, George Nnamdi Atuanya, Leopoldo Spadea, Carlo Salati, Marco Zeppieri
The aim of our minireview is to provide a brief overview of the diagnosis, clinical aspects, treatment options, management, and current literature available regarding herpes simplex keratitis (HSK). This type of corneal viral infection is caused by the herpes simplex virus (HSV), which can affect several tissues, including the cornea. One significant aspect of HSK is its potential to cause recurrent episodes of inflammation and damage to the cornea. After the initial infection, the HSV can establish a latent infection in the trigeminal ganglion, a nerve cluster near the eye...
March 25, 2024: World Journal of Virology
https://read.qxmd.com/read/38599771/congenital-and-postnatal-cytomegalovirus-case-series-and-state-of-the-science-for-neonatal-providers
#5
REVIEW
Taylor F Salemi, Vanessa R McLean, Amy J Jnah
Cytomegalovirus (CMV), a beta-herpes virus, is the most common viral infection in infants. Transmission may occur congenitally (cCMV) or postnatally (pCMV). Early detection and intervention are crucial in reducing morbidities, notable developmental delays, and sensorineural hearing loss. However, more than 90% of infants are asymptomatic at birth. Treatment involves intravenous ganciclovir or the oral prodrug, valganciclovir, drugs usually reserved for use with symptomatic infants because of the toxicity profile...
April 1, 2024: Neonatal Network: NN
https://read.qxmd.com/read/38561696/cytomegalovirus-colitis-as-intestinal-obstruction-in-an-immunocompetent-adolescent-a-case-report-and-literature-review
#6
JOURNAL ARTICLE
Jiongshan Ge, Yan Li, Di Shi, Jiaxin Wei, Jing Wang, Jihai Liu
BACKGROUND: Cytomegalovirus infection manifests varying clinical characteristics and severity in diverse populations with different immune statuses. The signs and symptoms of gastrointestinal involvement are nonspecific. Here, we present a case of cytomegalovirus colitis in an immunocompetent adolescent, which manifested as intestinal pseud-obstruction. CASE PRESENTATION: A 15-year-old man who had contracted novel coronavirus infection one month earlier was admitted to our hospital with fever, abdominal pain, and hematochezia...
April 1, 2024: BMC Infectious Diseases
https://read.qxmd.com/read/38527975/associations-between-different-antivirals-and-hospital-acquired-acute-kidney-injury-in-adults-with-herpes-zoster
#7
JOURNAL ARTICLE
Ruqi Xu, Qi Gao, Yuping Zhang, Yuxin Lin, Yanqin Li, Licong Su, Shiyu Zhou, Yue Cao, Peiyan Gao, Pingping Li, Fan Luo, Ruixuan Chen, Xiaodong Zhang, Sheng Nie, Xin Xu
BACKGROUND: To examine the association of use of different antivirals with hospital acquired acute kidney injury (AKI) among Chinese adults with herpes zoster. METHODS: The study selected 3273 adult patients who received antiviral therapy for herpes zoster during hospitalization from the China Renal Data System (CRDS). We identified and staged AKI using patient-level serum creatinine data according to the Kidney Disease Improving Global Outcomes (KDIGO) criteria...
March 26, 2024: Clinical Journal of the American Society of Nephrology: CJASN
https://read.qxmd.com/read/38501850/cytomegalovirus-treatment-in-solid-organ-transplantation-an-update-on-current-approaches
#8
REVIEW
Karen L Hardinger, Daniel C Brennan
OBJECTIVE: The article reviews the safety and efficacy of treatments for cytomegalovirus (CMV) in solid organ transplantation. DATA SOURCES: A literature review was conducted in PubMed, MEDLINE, and Clinicaltrials.gov from database inception through January 2024, using terms CMV, therapy, and solid organ transplantation. STUDY SELECTION AND DATA EXTRACTION: Clinical trials, meta-analyses, cohort studies, case reports, and guidelines were included...
March 19, 2024: Annals of Pharmacotherapy
https://read.qxmd.com/read/38496135/hemophagocytic-lymphohistiocytosis-associated-with-human-herpesvirus-6-hhv-6-infection-in-an-immunocompetent-adult-a-case-report
#9
Ateeb Ur Rahman, Fahad Baig, Umar Iqbal Javid Chaudhary, Muhammad Bilal Ashraf, Muhammad Daim Jawaid, Amna Chaudary, Munim Tariq
Hemophagocytic lymphohistiocytosis (HLH) is a rare disorder characterized by extreme immune activation and excessive inflammation. It has been reported in patients with familial cases, immunodeficiencies, malignancies, stem cell transplants, and viral etiologies. This report describes acquired HLH associated with Human herpesvirus-6 (HHV-6) infection in a 76-year-old previously healthy male. The patient was admitted to the hospital due to fever, chills, and abdominal pain. The diagnostic workup revealed gallbladder wall thickening on imaging, concerning for cholecystitis...
February 2024: Curēus
https://read.qxmd.com/read/38492206/optimization-of-ganciclovir-and-valganciclovir-starting-dose-in-children-by-machine-learning
#10
JOURNAL ARTICLE
Laure Ponthier, Julie Autmizguine, Benedicte Franck, Anders Åsberg, Philippe Ovetchkine, Alexandre Destere, Pierre Marquet, Marc Labriffe, Jean-Baptiste Woillard
BACKGROUND AND OBJECTIVES: Ganciclovir (GCV) and valganciclovir (VGCV) show large interindividual pharmacokinetic variability, particularly in children. The objectives of this study were (1) to develop machine learning (ML) algorithms trained on simulated pharmacokinetics profiles obtained by Monte Carlo simulations to estimate the best ganciclovir or valganciclovir starting dose in children and (2) to compare its performances on real-world profiles to previously published equation derived from literature population pharmacokinetic (POPPK) models achieving about 20% of profiles within the target...
March 16, 2024: Clinical Pharmacokinetics
https://read.qxmd.com/read/38474177/folate-targeted-nanocarriers-co-deliver-ganciclovir-and-mir-34a-5p-for-combined-anti-kshv-therapy
#11
JOURNAL ARTICLE
Fangling Li, Dongdong Cao, Wenyi Gu, Dongmei Li, Zhiyong Liu, Lin Cui
Kaposi's sarcoma-associated herpesvirus (KSHV) can cause a variety of malignancies. Ganciclovir (GCV) is one of the most efficient drugs against KSHV, but its non-specificity can cause other side effects in patients. Nucleic acid miR-34a-5p can inhibit the transcription of KSHV RNA and has great potential in anti-KSHV therapy, but there are still problems such as easy degradation and low delivery efficiency. Here, we constructed a co-loaded dual-drug nanocomplex (GCV@ZIF-8/PEI-FA+miR-34a-5p) that contains GCV internally and adsorbs miR-34a-5p externally...
March 2, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38473930/development-and-validation-of-an-hplc-uv-method-for-the-quantification-of-acyclovir-and-ganciclovir-in-the-plasma-of-pediatric-immunocompromised-patients
#12
JOURNAL ARTICLE
Martina Franzin, Rachele Ruoso, Rossella Del Savio, Riccardo Addobbati
Acyclovir and ganciclovir comprise the prophylaxis and treatment of herpesvirus and cytomegalovirus infections occurring in immunocompromised patients. Their therapeutic drug monitoring is fundamental because of interindividual variability leading to side effects and drug resistance and is performed through several techniques, such as liquid chromatography coupled with UV spectrophotometry (HPLC-UV) or mass spectrometry (LC-MS/MS). Therefore, we developed and validated a low-cost, non-time-consuming, and low-sample-consuming HPLC-UV method...
February 26, 2024: International Journal of Molecular Sciences
https://read.qxmd.com/read/38473298/activation-of-epstein-barr-virus-lytic-cycle-in-nasopharyngeal-carcinoma-cells-by-neo212-a-conjugate-of-perillyl-alcohol-and-temozolomide
#13
JOURNAL ARTICLE
Hannah Hartman-Houstman, Steve Swenson, Radu O Minea, Uttam K Sinha, Ming-Fu Chiang, Thomas C Chen, Axel H Schönthal
The Epstein-Barr virus (EBV) is accepted as a primary risk factor for certain nasopharyngeal carcinoma (NPC) subtypes, where the virus persists in a latent stage which is thought to contribute to tumorigenesis. Current treatments are sub-optimal, and recurrence occurs in many cases. An alternative therapeutic concept is aimed at triggering the lytic cycle of EBV selectively in tumor cells as a means to add clinical benefit. While compounds able to stimulate the lytic cascade have been identified, their clinical application so far has been limited...
February 26, 2024: Cancers
https://read.qxmd.com/read/38468986/multisystemic-disease-in-a-child-and-successful-recovery-with-antiviral-treatment
#14
Ana Sofia Rodrigues, Aida Correia de Azevedo, Susana Nobre, Paula Fonseca
Cytomegalovirus (CMV), a member of the Herpesviridae family, typically causes asymptomatic infections or mild mononucleosis-like syndromes in immunocompetent individuals. However, severe manifestations are well-documented in immunocompromised populations. This case report presents a previously healthy seven-year-old girl with a rare and complex presentation of primary CMV infection leading to severe multiorgan involvement, hepatosplenomegaly, cholestasis, bicytopenia, and a prolonged disease course. The patient's condition prompted an exhaustive diagnostic investigation, ruling out other potential causes...
February 2024: Curēus
https://read.qxmd.com/read/38448196/-the-504th-case-multiple-lymph-node-enlargement-renal-insufficiency-blindness-and-white-matter-lesions-of-the-brain
#15
JOURNAL ARTICLE
C Wei, Z Zhuang, Y L Li, X X Shi, Y B Wen, W Cao, S Y Fan, X Zhang, Y Zhang, W Zhang, D B Zhou
A 65-year-old male patient was admitted for recurrent lymph node enlargement for 5 years and elevated creatinine for 6 months. This patient was diagnosed with angioimmunoblastic T-cell lymphoma 5 years ago and underwent multiple lines of anti-tumor therapy, including cytotoxic chemotherapy; epigenetic modifying drugs such as chidamide and azacitidine; the immunomodulator lenalidomide; and targeted therapy such as rituximab, a CD20-targeting antibody, and brentuximab vedotin, which targets CD30. Although the tumor was considered stable, multiple virus activation (including BK virus, JC virus, and cytomegalovirus) accompanied by the corresponding organ damage (polyomavirus nephropathy, cytomegalovirus retinitis, and progressive multifocal leukoencephalopathy) occurred during anti-tumor treatment...
March 1, 2024: Zhonghua Nei Ke za Zhi [Chinese Journal of Internal Medicine]
https://read.qxmd.com/read/38444641/cytomegalovirus-colitis-in-a-patient-with-severe-treatment-refractory-ulcerative-colitis
#16
JOURNAL ARTICLE
Michelle M Bao, Juliana M Kennedy, Michael T Dolinger, David Dunkin, Joanne Lai, Marla C Dubinsky
BACKGROUND: Cytomegalovirus (CMV) can be reactivated in ulcerative colitis (UC), but its role in progression of inflammation is unclear. Risk factors include severe colitis and treatment with immunosuppressive medications, particularly corticosteroids and immunomodulators. METHODS: We report a case of cytomegalovirus colitis in a pediatric patient with pancolitis who had been refractory to aminosalicylate, infliximab, and ustekinumab and was in clinical remission and with transmural response on upadacitinib...
January 2024: Crohn's & colitis 360
https://read.qxmd.com/read/38436816/the-combinatorial-effect-of-ad-il-24-and-ad-hsv-tk-gcv-on-tumor-size-autophagy-and-upr-mechanisms-in-multiple-myeloma-mouse-model
#17
JOURNAL ARTICLE
Shima Poorghobadi, Seyed Younes Hosseini, Seyed Mehdi Sadat, Asghar Abdoli, Shiva Irani, Kazem Baesi
Multiple myeloma is a type of malignant neoplasia whose treatment has changed over the past decade. This study aimed to investigate the effects of combination of Adenovector-carrying interleukin-24 and herpes simplex virus 1 thymidine kinase/ganciclovir on tumor growth, autophagy, and unfolded protein response mechanisms in mouse model of multiple myeloma. Six groups of mice, including Ad-HSV-tk/GCV, Ad-IL-24, Ad-HSV-tk/IL-24, Ad-GFP, and positive and negative controls, were investigated, and each group was injected every 72 h...
March 4, 2024: Biochemical Genetics
https://read.qxmd.com/read/38430586/effect-of-resveratrol-on-herpesvirus-encephalitis-evidences-for-its-mechanisms-of-action
#18
JOURNAL ARTICLE
Ziwei Huang, Shan Li, Lishan Zhong, Yuan Su, Menghe Li, Xiaohui Wang, Zexu Wang, Zhiping Wang, Cuifang Ye, Zhe Ren, Xiao Wang, Qiongzhen Zeng, Kai Zheng, Yifei Wang
BACKGROUND: Herpes simplex virus type 1 (HSV-1)-induced herpes simplex encephalitis (HSE) has a high mortality rate in clinically immunocompromised patients, while recovered patients often experience neurological sequelae due to neuroinflammation. Nucleoside drugs and nucleoside analogues such as acyclovir and ganciclovir are mainly used in clinical treatment, and the emergence of resistant viral strains makes the development of new anti-herpesvirus encephalitis drugs urgent. Resveratrol is a multifunctional, plant-derived bioactive compound and its antiviral potential is attracting much attention...
February 22, 2024: Phytomedicine
https://read.qxmd.com/read/38417084/current-and-emerging-antiviral-agents-in-the-prevention-and-treatment-of-cytomegalovirus-in-pediatric-transplant-recipients
#19
JOURNAL ARTICLE
Kristen G Valencia Deray, Lara A Danziger-Isakov, Kevin J Downes
Despite current prophylaxis regimens, cytomegalovirus (CMV) is common in hematopoietic cell transplantation (HCT) and solid organ transplantation (SOT) and remains a significant cause of morbidity and mortality. Newer antiviral medications are reshaping the landscape for prevention and treatment of CMV DNAemia, infection, and disease. Letermovir is approved for CMV prevention in adult HCT patients and is attractive due to the absence of marrow suppression seen with ganciclovir/valganciclovir. Letermovir should not be routinely used for CMV treatment due to its low threshold for resistance...
February 28, 2024: Journal of the Pediatric Infectious Diseases Society
https://read.qxmd.com/read/38407965/suspected-retinal-toxicity-after-multiple-intravitreal-ganciclovir-injections-in-a-patient-of-cmv-retinitis
#20
JOURNAL ARTICLE
Rohan Kapoor, SriniVas Sadda, Mudit Tyagi
PURPOSE: Intravitreal Ganciclovir has been one of the treatments of choice for cytomegalovirus (CMV) retinitis and has been used extensively for its treatment since 1987. It has not been shown to have any major adverse effects. There are no reports on any retinal toxicity even after multiple, repeated injections. Herein, we report a rare case of retinal toxicity after multiple intravitreal injections in a patient of CMV retinitis. CASE REPORT: A 69-year-old one eyed male, who was on oral corticosteroids and systemic immunosuppression for Granulomatosis with Polyangiitis, presented with CMV retinitis in both eyes...
February 26, 2024: Ocular Immunology and Inflammation
keyword
keyword
43889
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.